Firms

Pictet Alternative Advisors

Pictet Alternative Advisors is the Pictet Group’s alternative investment business, managing private equity, private debt, real estate and hedge fund strategies for institutional and private clients. Its thematic private equity teams invest through specialist venture, growth and buyout funds and direct co-investments in technology, healthcare and environmental solutions. Technology includes enterprise AI, cybersecurity, fintech and deep tech; healthcare includes therapeutics, diagnostics, digital health and medical technology. Its direct private equity team also backs founder- and family-owned European businesses. It is distinct from the broader Pictet banking and wealth management group and from Pictet Asset Management.

Founded: —
Type: Venture capital

Funds6

Pictet Environment Co-Investment Fund I2026-07-142026-07-14$253M
Final close at USD253m in committed capital, above the USD200m target. Co-invests alongside private equity managers in buyout, late-stage growth and selected late-stage venture opportunities across greenhouse gas reduction, pollution control, circular economy, sustainable consumer and enabling technologies. A similarly named ELTIF compartment launched in April2024; its exact relationship and share of this committed total require legal documentation, so it is not counted as an additional USD253m vehicle.
Monte Rosa Co-Investments VI2026-06-052026-06-05—
Final close of Pictet’s sixth private equity co-investment vintage. The announced USD1.53bn total includes two side vehicles of aboutUSD50m each; exact main-fund-only commitments are not disclosed, so the amount is left unknown. Primarily buyout, plus selected growth and venture co-investments across technology, healthcare, industrials and consumer companies, mainly in North America and Europe. USD1.0bn was the initial target, not the final amount.
Pictet Private Equity Entrepreneur Capital I2026-03-252026-03-25€403M
Final close at EUR403m for PAA’s first direct private equity strategy. Acquires lower mid-market founder- and family-owned businesses in DACH and the UK, focusing on B2B services and education, with technology transformation and expansion strategies.
Pictet Thematic Private Equity Technology Fund II2024-09-242024-09-24$204M
Final close announced Sept24,2024 at more than USD200m. Pictet’s January2026 presentation reports fund size USD204m as of Sept30,2025 (page28), which supplies the precise reported amount. Global venture, growth and buyout technology fund investments and direct co-investments, including enterprise software, data and AI, cybersecurity and fintech. Launched in late2022; final close is within the research window.
Pictet Thematic Private Equity Health Fund I2023-12-132023-12-13$320M
Final close of the first healthcare-focused thematic private equity fund, launched in2022. Invests in specialist venture, growth and buyout funds and direct co-investments across therapeutics, diagnostics, digital health, medical technology and healthcare services. USD320m is the reported final fund size; USD300m was its target.
Pictet Thematic Private Equity SICAV-RAIF – Technology Fund III——
A Luxembourg SICAV-RAIF compartment marketed in Pictet’s January2026 presentation, with a USD250m target. The target is not a verified close, so the amount and exact launch date remain unknown. Invests primarily in global venture, growth and buyout funds (about60%) plus co-investments (about40%), focusing on enterprise AI, fintech, cybersecurity, consumer and deep tech. PAA is the investment-strategy platform; the presentation identifies Pictet Asset Management (Europe) S.A. in the legal fund disclosures.

Team

Operations and support

Adel KhalilPrincipal, North America

Alexander BinzerPrincipal, Direct Private Equity

Alexander LukeschHead of Investments, Multi-Manager Real Estate

Andreas KleinHead of Private Debt

Andrzej SokolowskiHead of UK, Direct Private Equity

Anjali BastianpillaiTechnology Fund Advisory Committee Member (affiliated Pictet Asset Management)

Aurelie GoupilVice-President, Direct Private Equity

Beatrice ReitanoHead of Investor Relations

Brendon KortekaasHead of Value Creation, Direct Private Equity

Chiara BrambillascaSenior Associate, Health Thematics

Chris ZhuAffiliated Senior Associate, Asia (Bank Pictet & Cie (Asia) Ltd)

Christopher SeilernTechnology Fund Advisory Committee Member (affiliated Pictet Wealth Management)

Chuang ZhuPrincipal, Private Equity Thematics Technology

David Braga MaltaPrincipal, Health Thematics

David LogcherVice-President, Direct Private Equity

David MarechalDeputy Head of Private Equity; Co-Head of Europe

Edmund BuckleyGlobal Co-Head of Private Equity; Head of Direct Private Equity

Elif AktuğChief Executive Officer

Esther HuberInvestment Professional, Direct Private Equity

Fernando López ZarazagaAnalyst, Europe

Francisco SilvaManager, Europe

Hadelyn du ChastelInvestment Manager, Europe

Ivo WeinoehrlTechnology Fund Advisory Committee Member (affiliated Pictet Asset Management)

Jacqueline XuAffiliated Investment Leader, Asia (Bank Pictet & Cie (Asia) Ltd)

Javier Lopez QuesadaAnalyst, Europe

John GladwynTechnology Fund Advisory Committee Member (affiliated Pictet Asset Management)

Lorenzo FuscoPrincipal, Environment Thematics

Lorenzo SpinelliAssociate, North America

Louis MaddisonInvestment Professional, Direct Private Equity

Luis SantosInvestment Manager, Europe

Maurizio ArrigoGlobal Co-Head of Private Equity

Nathalie KriegerCo-Head of Europe; Head of Asia

Nermin NukovicPrincipal, Europe

Nicolas SchwynInvestment Manager, Private Equity Thematics Technology

Nicolas ThomasPrincipal, Environment Thematics

Nikolaus HubmannHead of DACH, Direct Private Equity

Pablo DíezAssociate, Europe

Peter LingenTechnology Fund Advisory Committee Member (affiliated Pictet Asset Management)

Pierre StadlerHead of Thematic Private Equity

Romain de PlantaInvestment Manager, Europe

Sean HowardPrincipal, Direct Private Equity

Stanislas ChanavatPrincipal, Private Equity Thematic Technology

Thibaud RoulinHead of North America

Trudi Usher BoardmanHead of Hedge Funds

Victoria DurandInvestment Manager, Europe

Yann MauronPrincipal, Health Thematics

Yannick PolysiusVice-President, Direct Private Equity

Yves KramerTechnology Fund Advisory Committee Member (affiliated Pictet Asset Management)

Zsolt KohalmiDeputy Chief Executive Officer; Global Head of Real Estate

Co-investing

abrdn Inc.

Atalanta Therapeutics$97M · 2025-01-28

EQT Life Sciences

Atalanta Therapeutics$97M · 2025-01-28

F-Prime Capital

Atalanta Therapeutics$97M · 2025-01-28

GHR Foundation

Atalanta Therapeutics$97M · 2025-01-28

Mirae Asset

Atalanta Therapeutics$97M · 2025-01-28

Investments

$97M2025-01-28

Atalanta Therapeutics

EQT Life Sciences, Sanofi Ventures, RiverVest Venture Partners, Novartis Venture Fund, Mirae Asset, F-Prime Capital, GHR Foundation, Pictet Alternative Advisors, abrdn Inc.

team@apexlogos.ai23 hours ago
Pictet Alternative Advisors is represented separately from the existing generic Pictet investor5964 and Pictet Asset Management. The logo combines the two authentic complementary SVG elements used in the official site header (crest and wordmark); it is the group brand used by this business. Published coverage totals49 unique people across current leadership and direct/technology pages, the January2026 private equity platform roster, and six Technology Fund Advisory Committee members. Jacqueline Xu and Chris Zhu are explicitly affiliated Asia research/marketing professionals employed by Bank Pictet & Cie (Asia) Ltd; the six technology committee members are employed by PAM/PWM. Their roles record those affiliations, not PAA employment. Current website ranks supersede older January2026 ranks for Chuang Zhu, Nicolas Schwyn and Maurizio Arrigo. Doc Horn’s total-return public equity role is not assigned to PAA from the broad alternative platform contact list. Fund amounts distinguish exact closes, reported fund size and targets: HealthI320mUSD; TechII initiallyabove200m, laterreported204mUSD; EntrepreneurI403mEUR; EnvironmentI253mUSD; TechIII250mUSD target only, amount and exact launch day unknown. The April2024 similarly named Environment ELTIF compartment requires legal relationship checks; no duplicate253m size assigned. Portfolio company logos in the tech presentation can include indirect exposure through primary funds; they do not automatically establish direct PAA startup investments. Atalanta’s issuer explicitly names PAA in its January2025 SeriesB, which is linked to the existing financing. Wider public team and portfolio coverage remains incomplete. A sixth record, Monte Rosa Co-Investments VI, has a June5,2026 final close; the USD1.53bn headline includes two roughlyUSD50m side vehicles. The exact main-fund-only amount remains unknown, and the two unnamed side vehicles are not invented as separate records.